Shared by
beno
Fundamentals
N/a
Catalysts / News / Painting the picture
-Diffusion Pharmaceuticals Presents Data Suggesting Optimized TSC Dosing Regimen Increases Survival in Newly Diagnosed Inoperable Glioblastoma Patients
-$19m ATM S-1 on October
-November 13th prospectus for 11.428m common shares at $0.35
-Should have 16,121,862 shares outstanding after prospectus complete
Technical Analysis
-Daily chart: huge downtrend with lots of wicks, piggy
-Recent support at 0.54
-Formed nice level at 0.58 during PM on which I took the trade
Original Plan / Strategy
First Test of 0.58 level
Review
Had fantasy orders in at all times, one good trade.
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2019-12-11 08:36:19 | DFFN | buy | $0.5836 | long |
| 2019-12-11 08:36:25 | DFFN | buy | $0.5817 | long |
| 2019-12-11 08:36:25 | DFFN | buy | $0.5794 | long |
| 2019-12-11 08:36:25 | DFFN | buy | $0.5773 | long |
| 2019-12-11 08:36:25 | DFFN | buy | $0.5753 | long |
| 2019-12-11 08:42:20 | DFFN | sell | $0.5965 | long |
| 2019-12-11 08:43:45 | DFFN | sell | $0.6004 | long |
| 2019-12-11 08:44:32 | DFFN | sell | $0.6044 | long |
| 2019-12-11 08:44:44 | DFFN | sell | $0.6090 | long |
| 2019-12-11 08:46:04 | DFFN | sell | $0.6134 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!